Valens Semiconductor Reports Fourth Quarter and Full Year 2024 Results
Key Financial Highlights:
- Q4 revenues:
$16.7 million , exceeding the top end of our guidance and marking the fourth consecutive quarter of revenue growth. - Q4 gross margin: 60.4% GAAP; 64.5% non-GAAP.
- Cash, cash equivalents and short-term deposits:
$131.0 million .

"2024 was a challenging year for many companies around the world, including semiconductor companies in many markets, and these challenges affected Valens as well. However, although our sales were slowed by continued inventory digestion and weakness in our customer markets, we believe that we are emerging from the bottom of the cycle, and that 2025 will prove a turnaround year for our company," said
"Given the continued validation of our groundbreaking technology and our fortress balance sheet, we are well positioned to capitalize on exciting growth opportunities and to expand Valens' business," said
Q4 2024 Financial Highlights:
- Q4 revenues reached
$16.7 million , exceeding our guidance of$16.0-$16.3 million , compared to$16.0 million in Q3 2024 and$21.9 million in Q4 2023.
- Q4 Cross-Industry Business ("CIB") revenues, including Acroname revenues, accounted for approximately 70% of total revenues at$11.7 million compared to$9.4 million dollars in Q3 2024 and$15.8 million in Q4 2023.
-Q4 Automotive revenues accounted for approximately 30% of total revenues at$5.0 million , compared to$6.6 million dollars in Q3 2024 and$6.1 million in Q4 2023. - Q4 GAAP gross margin was 60.4% (non-GAAP gross margin was 64.5%), above the mid-point of the guidance. This is compared to a GAAP gross margin of 56.4% for Q3 2024 and 61.7% for Q4 2023 (non-GAAP gross margin of 60.7% in Q3 2024 and 63.1% in Q4 2023). On a segment basis, Q4 gross margin from the CIB was 64.7% and gross margin from Automotive was 50.5%. This compares to a Q3 2024 gross margin of 70.2% and 37.0%, respectively, and a Q4 2023 gross margin of 76.6% and 22.6%, respectively. The increase in Q4 automotive gross margin was due to an optimization of our product cost. The decrease in gross margin of the CIB was due to a product mix shift and lower fixed cost absorption.
- Q4 GAAP net loss decreased to
$(7.3) million , compared to a net loss of$(10.4) million dollars in Q3 2024 and a net profit of$2.8 million dollars in Q4 2023. - Q4 adjusted EBITDA was a loss of
$(3.7) million , better than the guidance range of$(4.0)-$(4.9) million EBITDA loss. This compares to an adjusted EBITDA loss of$(5.1) million dollars in Q3 2024 and an adjusted EBITDA profit of$2.2 million dollars in Q4 2023.
Full Year 2024 Financial Highlights
- 2024 revenues reached
$57.9 million , compared to$84.2 million in the fiscal year of 2023.
- CIB revenues accounted for 62.7% (equivalent to$36.3 million , of which Acroname contributed$3.4 million ) compared to 68.2% (equivalent to$57.4 million ) in 2023, as customers worked through excess inventory, which slowed the pace of orders.
- Automotive revenues accounted for 37.3% (equivalent to$21.6 million ), compared to 31.8% (equivalent to$26.8 million ) in 2023. The decrease is due to gradual price erosion and a reduction in the number of units sold toMercedes Benz . - 2024 GAAP gross margin was 59.2% (non-GAAP gross margin was 62.9%). This compared to a GAAP gross margin of 62.5% for 2023 (and non-GAAP gross margin of 63.9%). On a segment basis, 2024 gross margin from the CIB was 71.0% and gross margin from Automotive was 39.5%. This compares to gross margin of 77.1% and 31.1%, respectively, in 2023. The increase in 2024 automotive gross margin was due to an optimization of our product cost. The decrease in gross margin of the CIB was due to a product mix shift and lower fixed cost absorption.
- 2024 GAAP net loss was
$(36.6) million , compared to a GAAP net loss of$(19.7) million in 2023. - Adjusted EBITDA loss in 2024 was
$(21.1) million , compared to$(10.3) million in 2023. - Robust balance sheet of
$131.0 million in cash, cash equivalents and short-term deposits, and no debt, as ofDecember 31, 2024 , compared to$133.1 at the end ofSeptember 2024 , and$142.0 million as ofDecember 31, 2023 . - Inventory balance of
$10.2 million onDecember 31, 2024 , down from$11.7 million onSeptember 30, 2024 , and$13.8 million onDecember 31, 2023 .
2024 Business Highlights:
- Achieved three design wins with leading European automotive OEMs for Valens' MIPI A-PHY standard-compliant chipsets.
- Completed the acquisition of Acroname to accelerate the introduction of new innovative USB products for the industrial and professional audio video markets.
- Targeted new verticals that have high growth potential, including industrial machine vision, with recently released chipsets.
- Commercialized the VS6320 chipset, which has attracted over 50 customers for professional audio-video and machine vision applications that have started development of products, mainly for the video conferencing market, that are expected to be commercialized during the second half of 2025.
- Presented a five-year plan that, if achieved, could see Valens more than quadruple its top-line revenues by 2029.
- Announced a share repurchase program of
$10 million , which was completed inJanuary 2025 .
Financial Outlook for Q1 and Full Year of 2025
For Q1 2025,
For the full year 2025,
Goals for 2025
- Professional Audio-Video: Partial recovery from the inventory digestion cycle; adoption and commercialization of VS6320-based products for the video conferencing market.
- Industrial Machine Vision: Design win announcements based on the VS6320 and VA7000 chipsets.
- Automotive: Design win announcements with leading OEMs.
- Acquisitions: Identify potential synergetic acquisitions and close at least one, assuming the identification of a relevant target.
Disclaimer:
Conference Call Information
NYSE Rule 203.01 Annual Financial Report Announcement
Pursuant to Rule 203.01 of the New York Stock Exchange Manual,
Forward-Looking Statements
This press release includes "forward-looking statements" within the meaning of the "safe harbor" provisions of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words such as "estimate," "plan," "project," "forecast," "intend," "will," "expect," "anticipate," "believe," "seek," "target" or other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. These forward-looking statements include, but are not limited to, statements regarding our anticipated future results, including financial results, our five-year plan, currency exchange rates, and contract wins, and future economic and market conditions. These statements are based on various assumptions, whether or not identified in this press release, and on the current expectations of
About Valens Semiconductor
|
||||
SUMMARY OF FINANCIAL RESULTS |
||||
( |
||||
|
Three Months Ended
|
Year Ended
|
||
|
2024 |
2023 |
2024 |
2023 |
Revenues |
16,665 |
21,940 |
57,859 |
84,161 |
Gross Profit |
10,073 |
13,527 |
34,277 |
52,592 |
Gross Margin |
60.4 % |
61.7 % |
59.2 % |
62.5 % |
Net Income (Loss) |
(7,317) |
2,790 |
(36,583) |
(19,661) |
Working Capital[1] |
133,577 |
158,763 |
133,577 |
158,763 |
Cash, cash equivalents and short-term deposits[2] |
130,955 |
142,020 |
130,955 |
142,020 |
Net cash (used in) operating activities |
(330) |
(4,136) |
1,019 |
(6,359) |
Non-GAAP Financial Data |
|
|
|
|
Non-GAAP Gross Margin[3] |
64.5 % |
63.1 % |
62.9 % |
63.9 % |
Adjusted EBITDA Income (Loss)[4] |
(3,688) |
2,212 |
(21,063) |
(10,259) |
Non-GAAP Income (Loss) per share
(in |
|
|
|
|
|
||||||||
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS |
||||||||
( |
||||||||
|
Three Months Ended |
|
Year Ended |
|||||
|
2024 |
|
2023 |
|
2024 |
|
2023 |
|
|
|
|
|
|
|
|
|
|
REVENUES |
16,665 |
|
21,940 |
|
57,859 |
|
84,161 |
|
COST OF REVENUES |
(6,592) |
|
(8,413) |
|
(23,582) |
|
(31,569) |
|
GROSS PROFIT |
10,073 |
|
13,527 |
|
34,277 |
|
52,592 |
|
OPERATING EXPENSES: |
|
|
|
|
|
|
|
|
Research and development expenses |
(10,061) |
|
(8,631) |
|
(40,475) |
|
(48,171) |
|
Sales and marketing expenses |
(4,666) |
|
(3,984) |
|
(18,302) |
|
(17,314) |
|
General and administrative expenses |
(3,671) |
|
(2,648) |
|
(16,465) |
|
(14,024) |
|
Change in earnout liability |
(85) |
|
- |
|
(377) |
|
- |
|
TOTAL OPERATING EXPENSES |
(18,483) |
|
(15,263) |
|
(75,619) |
|
(79,509) |
|
OPERATING LOSS |
(8,410) |
|
(1,736) |
|
(41,342) |
|
(26,917) |
|
Change in fair value of Forfeiture Shares |
(1) |
|
95 |
|
37 |
|
1,713 |
|
Financial income, net |
1,136 |
|
4,477 |
|
4,795 |
|
5,637 |
|
INCOME (LOSS) BEFORE INCOME TAXES |
(7,275) |
|
2,836 |
|
(36,510) |
|
(19,567) |
|
INCOME TAXES |
(44) |
|
(51) |
|
(96) |
|
(112) |
|
INCOME (LOSS) AFTER INCOME TAXES |
(7,319) |
|
2,785 |
|
(36,606) |
|
(19,679) |
|
Equity in earnings of investee |
2 |
|
5 |
|
23 |
|
18 |
|
NET INCOME (LOSS) |
(7,317) |
|
2,790 |
|
(36,583) |
|
(19,661) |
|
|
|
|
|
|
|
|
|
|
Other comprehensive income: |
|
|
|
|
|
|
|
|
Change in unrealized gains on cash flow hedges |
601 |
|
- |
|
601 |
|
- |
|
TOTAL COMPREHENSIVE LOSS |
(6,716) |
|
2,790 |
|
(35,982) |
|
(19,661) |
|
EARNINGS PER SHARE DATA:
|
|
|
|
|
|
|
|
|
BASIC AND DILUTED NET INCOME (LOSS)
PER ORDINARY SHARE
[6]
(in |
|
|
|
|
|
|
|
|
WEIGHTED AVERAGE NUMBER OF SHARES AND VESTED RSUS USED IN COMPUTING NET INCOME (LOSS) PER ORDINARY SHARE |
106,683,126 |
|
102,964,797 |
|
105,477,191 |
|
101,985,939 |
|
|
|
|
|
|
|
|
|
|
|
||||||
|
||||||
CONDENSED CONSOLIDATED BALANCE SHEETS |
||||||
( |
||||||
ASSETS |
|
|
|
|
||
CURRENT ASSETS Cash and cash equivalents |
|
|
35,423 |
|
|
17,261 |
Short-term deposits |
|
|
95,532 |
|
|
124,759 |
Restricted Short-term deposit |
|
|
1,138 |
|
|
- |
Trade accounts receivables |
|
|
7,751 |
|
|
14,642 |
Inventories |
|
|
10,155 |
|
|
13,836 |
Prepaid expenses and other current assets |
|
|
3,904 |
|
|
4,196 |
TOTAL CURRENT ASSETS |
|
|
153,903 |
|
|
174,694 |
LONG-TERM ASSETS: |
|
|
|
|
|
|
Property and equipment, net |
|
|
3,555 |
|
|
2,954 |
Operating lease right-of-use assets |
|
|
7,458 |
|
|
2,202 |
Intangible assets |
|
|
4,702 |
|
|
- |
|
|
|
1,847 |
|
|
- |
Other assets |
|
|
687 |
|
|
708 |
TOTAL LONG-TERM ASSETS |
|
|
18,249 |
|
|
5,864 |
TOTAL ASSETS |
|
|
172,152 |
|
|
180,558 |
|
|
|
|
|
|
|
LIABILITIES AND SHAREHOLDERS' EQUITY
CURRENT LIABILITIES |
|
|
20,326 |
|
|
15,931 |
LONG-TERM LIABILITIES: |
|
|
|
|
|
|
Forfeiture shares |
|
|
1 |
|
|
38 |
Operating leases liabilities |
|
|
6,645 |
|
|
190 |
Earnout liability |
|
|
2,413 |
|
|
- |
Other long-term liabilities |
|
|
79 |
|
|
95 |
TOTAL LONG-TERM LIABILITIES |
|
|
9,138 |
|
|
323 |
TOTAL LIABILITIES |
|
|
29,464 |
|
|
16,254 |
|
|
|
|
|
|
|
TOTAL SHAREHOLDERS' EQUITY |
|
|
142,688 |
|
|
164,304 |
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY |
|
|
172,152 |
|
|
180,558 |
|
|
|
|
|
|
|
|
||||||
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS |
||||||
( |
||||||
|
|
Three Months Ended
|
Year Ended
|
|||
|
|
2024 |
2023 |
2024 |
2023 |
|
CASH FLOW FROM OPERATING ACTIVITIES |
|
|
|
|
|
|
Net income (loss) for the period |
|
(7,317) |
2,790 |
(36,583) |
|
(19,661) |
Adjustments to reconcile net income (loss) to net cash used in operating activities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
Depreciation and amortization |
|
788 |
439 |
2,546 |
|
1,632 |
Stock-based compensation |
|
3,859 |
3,509 |
15,118 |
|
15,026 |
Exchange rate differences |
|
(693) |
(2,707) |
660 |
|
945 |
Realized and unrealized losses on non-designated derivative instruments |
|
609 |
- |
609 |
|
- |
Interest on short-term deposits |
|
(361) |
(481) |
244 |
|
(848) |
Change in fair value of forfeiture shares |
|
1 |
(95) |
(37) |
|
(1,713) |
Change in earnout liability |
|
85 |
- |
377 |
|
- |
Reduction in the carrying amount of ROU assets |
|
(119) |
410 |
1,500 |
|
1,874 |
Equity in earnings of investee, net of dividend received |
|
(4) |
(12) |
17 |
|
1 |
Changes in operating assets and liabilities: |
|
|
|
|
|
|
Trade accounts receivable |
|
(534) |
(7,020) |
7,185 |
|
(3,166) |
Prepaid expenses and other current assets |
|
(294) |
(557) |
991 |
|
489 |
Inventories |
|
1,503 |
3,066 |
6,178 |
|
9,980 |
Other long-term assets |
|
19 |
(168) |
12 |
|
(174) |
Current Liabilities |
|
1,906 |
(2,931) |
3,496 |
|
(9,187) |
Change in operating lease liabilities |
|
209 |
(347) |
(1,278) |
|
(1,598) |
Other long-term liabilities |
|
13 |
(32) |
(16) |
|
41 |
Net cash provided by (used in) operating activities |
|
(330) |
(4,136) |
1,019 |
|
(6,359) |
CASH FLOWS FROM INVESTING ACTIVITIES: |
|
|
|
|
|
|
Investment in short-term deposits |
|
(37,879) |
(32,682) |
(141,541) |
|
(206,024) |
Maturities of short-term deposits |
|
40,695 |
41,804 |
170,113 |
|
208,561 |
Purchase of property and equipment |
|
(880) |
(86) |
(1,867) |
|
(1,185) |
Investment in a restricted short-term deposit |
|
(1,120) |
- |
(1,120) |
|
- |
Derivative instruments of non-designated hedges |
|
(4) |
- |
(4) |
|
- |
Cash paid for business combination, net of cash acquired
|
|
- |
- |
(7,800) |
|
- |
Net cash provided by investing activities |
|
812 |
9,036 |
17,781 |
|
1,352 |
CASH FLOWS FROM FINANCING ACTIVITIES: |
|
|
|
|
|
|
Repurchase of Ordinary Shares |
|
(1,016) |
- |
(1,016) |
|
- |
Exercise of stock options |
|
169 |
233 |
861 |
|
1,498 |
Net cash provided by (used in) financing activities |
|
(847) |
233 |
(155) |
|
1,498 |
|
|
|
|
|
|
|
Effect of exchange rate changes on cash and cash equivalents |
|
345 |
942 |
(483) |
|
746 |
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS |
|
(20) |
6,075 |
18,162 |
|
(2,763) |
CASH AND CASH EQUIVALENTS AT THE BEGINNING OF THE PERIOD |
|
35,443 |
11,186 |
17,261 |
|
20,024 |
CASH AND CASH EQUIVALENTS AT THE END OF THE PERIOD |
|
35,423 |
17,261 |
35,423 |
|
17,261 |
|
|
|
|
|
|
|
SUPPLEMENT DISCLOSURE OF CASH FLOW INFORMATION |
|
|
|
|
|
|
Cash paid for taxes |
|
20 |
31 |
122 |
|
293 |
|
|
|
|
|
|
|
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES |
|
|
|
|
|
|
Trade accounts payable on account of property and equipment |
|
260 |
486 |
569 |
|
611 |
Repurchase of Ordinary Shares |
|
597 |
- |
597 |
|
- |
Fair value of earnout liability assumed in business combination |
|
- |
- |
2,036 |
|
- |
Operating lease liabilities arising from obtaining operating right-of-use assets and lease modification |
|
682 |
24 |
6,094 |
|
398 |
RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES
(
The following table provides a reconciliation of Net income (loss) to Adjusted EBITDA, a non-GAAP measure. Adjusted EBITDA is defined as Net profit (loss) before financial income (expense), net, income taxes, equity in earnings of investee and depreciation and amortization, further adjusted to exclude share-based compensation, change in fair value of Forfeiture Shares, change in earnout liability and certain batch production incident expenses, which may vary from period-to-period. We caution investors that amounts presented in accordance with our definition of Adjusted EBITDA may not be comparable to similar measures disclosed by other issuers, because not all issuers calculate Adjusted EBITDA in the same manner. Adjusted EBITDA should not be considered as an alternative to Net income (loss) or any other performance measures derived in accordance with GAAP or as an alternative to cash flows from operating activities as a measure of our liquidity.
Although we provide guidance for Adjusted EBITDA, we are not able to provide guidance for projected Net profit (loss), the most directly comparable GAAP measures. Certain elements of Net profit (loss), including share-based compensation expenses and warrant valuations, are not predictable due to the high variability and difficulty of making accurate forecasts. As a result, it is impractical for us to provide guidance on Net profit (loss) or to reconcile our Adjusted EBITDA guidance without unreasonable efforts. Consequently, no disclosure of projected Net profit (loss) is included. For the same reasons, we are unable to address the probable significance of the unavailable information.
|
Three Months Ended
|
Year Ended
|
|||
|
2024 |
2023 |
2024 |
2023 |
|
|
|
|
|
|
|
Net income (loss) |
(7,317) |
2,790 |
(36,583) |
(19,661) |
|
Adjusted to exclude the following: |
|
|
|
|
|
|
Change in fair value of Forfeiture Shares |
1 |
(95) |
(37) |
(1,713) |
|
Change in earnout liability |
85 |
- |
377 |
- |
|
Financial income, net |
(1,136) |
(4,477) |
(4,795) |
(5,637) |
|
Income taxes |
44 |
51 |
96 |
112 |
|
Equity in earnings of investee |
(2) |
(5) |
(23) |
(18) |
|
Certain batch production incident expenses (income) |
(10) |
- |
2,238 |
- |
|
Depreciation and amortization |
788 |
439 |
2,546 |
1,632 |
|
Stock-based compensation expenses |
3,859 |
3,509 |
15,118 |
15,026 |
Adjusted EBITDA income (loss) |
(3,688) |
2,212 |
(21,063) |
(10,259) |
|
||||
RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES |
||||
( |
||||
|
||||
The following tables provide a calculation of the GAAP Income (Loss) per ordinary share and reconciliation to |
||||
|
Three Months Ended
|
Year Ended
|
||
GAAP Income (Loss) per ordinary Share |
2024 |
2023 |
2024 |
2023 |
|
|
|
|
|
GAAP Net income (loss) used for computing Income (Loss) per ordinary Share |
(7,317) |
2,790 |
(36,583) |
(19,661) |
Earnings Per Share Data: |
|
|
|
|
GAAP income (loss) per ordinary Share (in |
|
|
|
|
Weighted average number of shares and vested RSUs used in computing net income (loss) per ordinary share |
106,683,126 |
102,964,797 |
105,477,191 |
101,985,939 |
|
Three Months Ended
|
Year Ended
|
||
Non-GAAP Income (Loss) per ordinary Share |
2024 |
2023 |
2024 |
2023 |
|
|
|
|
|
GAAP Net income (loss) |
(7,317) |
2,790 |
(36,583) |
(19,661) |
Adjusted to exclude the following: |
|
|
|
|
Stock based compensation |
3,859 |
3,509 |
15,118 |
15,026 |
Depreciation and amortization |
788 |
439 |
2,546 |
1,632 |
Certain batch production incident expenses (income) |
(10) |
- |
2,238 |
- |
Change in earnout liability |
85 |
- |
377 |
- |
Change in fair value of Forfeiture Shares |
1 |
(95) |
(37) |
(1,713) |
Total Income (Loss) used for computing Income (Loss) per ordinary Share |
(2,594) |
6,643 |
(16,341) |
(4,716) |
Earnings Per Share Data: |
|
|
|
|
Non-GAAP Income (Loss) per ordinary Share (in |
|
|
|
|
Weighted average number of shares and vested RSUs used for computing net income (loss) per ordinary share |
106,683,126 |
102,964,797 |
105,477,191 |
101,985,939 |
[1] Working Capital is calculated as Total Current Assets, less Total Current Liabilities, as of the last day of the period.
[2] As of the last day of the period.
[3] Non-GAAP Gross Margin is defined as: GAAP Gross Profit excluding share-based compensation and depreciation and amortization expenses, divided by revenue. For the three months ended
[4]Adjusted EBITDA is defined as Net profit (loss) before financial income (expense), net, income taxes, equity in earnings of investee and depreciation and amortization, further adjusted to exclude share-based compensation, certain batch production incident expenses and change in fair value of Forfeiture Shares and inearnout liability, which may vary from period-to-period. We caution investors that amounts presented in accordance with our definition of Adjusted EBITDA may not be comparable to similar measures disclosed by other issuers, because not all issuers calculate Adjusted EBITDA in the same manner. Adjusted EBITDA should not be considered as an alternative to Net loss or any other performance measures derived in accordance with GAAP or as an alternative to cash flows from operating activities as a measure of our liquidity. Please refer to the appendix at the end of this press release for a reconciliation to the most directly comparable measure in accordance with GAAP.
[5] See reconciliation of GAAP to non-GAAP financial measures.
[6] See footnote 5.
For more information, please contact:
Investor Relations Manager
michal.benari@valens.com
MS-IR
msegal@ms-ir.com
Media Contact:
Head of Communications
yoni.dayan@valens.com
Infographic - https://mma.prnewswire.com/media/2626359/Valens_Semiconductor.jpg
Logo - https://mma.prnewswire.com/media/2309625/Valens_Semiconductor_Logo.jpg

View original content:https://www.prnewswire.com/news-releases/valens-semiconductor-reports-fourth-quarter-and-full-year-2024-results-302385990.html
SOURCE